Results 91 to 100 of about 11,200,376 (224)
Tumor microenvironment drives cancer formation and progression. We analyzed the role of human cancer‐associated adipocytes from patients with renal cell carcinoma (RCC) stratified as lean, overweight, or obese. RNA‐seq demonstrated that, among the most altered genes involved in the tumor–stroma crosstalk, are ADAM12 and CYP1B1, which were proven to be ...
Sepehr Torabinejad+13 more
wiley +1 more source
On the Anharmonic Pulsations of the Standard Model [PDF]
C. Prasad, E. A. Milne
openalex +1 more source
Large multidimensional digital images of cancer tissue are becoming prolific, but many challenges exist to automatically extract relevant information from them using computational tools. We describe publicly available resources that have been developed jointly by expert and non‐expert computational biologists working together during a virtual hackathon
Sandhya Prabhakaran+16 more
wiley +1 more source
The Mixed Aggregate Preference Logit Model: A Machine Learning Approach to Modeling Unobserved Heterogeneity in Discrete Choice Analysis [PDF]
This paper introduces the Mixed Aggregate Preference Logit (MAPL, pronounced "maple'') model, a novel class of discrete choice models that leverages machine learning to model unobserved heterogeneity in discrete choice analysis. The traditional mixed logit model (also known as "random parameters logit'') parameterizes preference heterogeneity through ...
arxiv
Exactly renormalizable model in quantum field theory III. Renormalization in the case of two V-particles [PDF]
Th.W. Ruijgrok
openalex +1 more source
The authors conducted a retrospective study of 94 patients with advanced cancer who underwent next‐generation sequencing (NGS) gene panel analysis and received targeted treatments when applicable. Results further support evidence indicating that molecular profiling provides clinical benefit.
Michaël Dang+3 more
wiley +1 more source
Howell's Relief Maps and the Naturalistic Land Model [PDF]
George C. Curtis
openalex +1 more source
Analysis of ESR1 mutations in plasma cell‐free DNA (cfDNA) is highly important for the selection of treatment in patients with breast cancer. Using multiplex‐ddPCR and identical blood draws, we investigated whether circulating tumor cells (CTCs) and cfDNA provide similar or complementary information for ESR1 mutations.
Stavroula Smilkou+11 more
wiley +1 more source